Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Targeted Oncology

Issue 4/2011

Content (9 Articles)

Editorial

The carriages to the good drivers

Jean-François Morère

Review

Heart to heart with trastuzumab: a review on cardiac toxicity

Serena Di Cosimo

Review

Cardiovascular toxicity of anti-angiogenic drugs

Gaetan des Guetz, Bernard Uzzan, Kader Chouahnia, Jean-François Morère

Review

Hematologic toxicities of small molecule tyrosine kinase inhibitors

Nicholas A. Barber, Wais Afzal, Mojtaba Akhtari

Review

Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management

Rebecca L. Brown

Review

Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents

Andreia Costa, Sabine Tejpar, Hans Prenen, Eric Van Cutsem

Review

Pulmonary toxicities from targeted therapies: a review

Nicholas A. Barber, Apar Kishor Ganti

Review

Targeted agents: review of toxicity in the elderly metastatic colorectal cancer patients

Flora Kyriakou, Panteleimon Kountourakis, Demetris Papamichael

Day-to-Day Practice

Posterior reversible encephalopathy syndrome induced by anti-VEGF agents

Camille Tlemsani, Olivier Mir, Pascaline Boudou-Rouquette, Olivier Huillard, Karin Maley, Stanislas Ropert, Romain Coriat, François Goldwasser

Sep 11
Issue: 3/2011
Mar 12
Issue: Special Issue 1/2012
Special focus: Biosimilars

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits